CL
UTHR icon

CSS LLC’s United Therapeutics UTHR Stock Holding History

CSS LLC’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,000
Closed -$471K – 1174
2022
Q2 		$471K Buy
+2,000
New +$407K 0.02% 590
2015
Q2 		– Sell
-8,000
Closed -$1.38M – 793
2015
Q1 		$1.38M Buy
+8,000
New +$1.22M 0.07% 232

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

CSS LLC's UTHR Position: Q1 2026 in Review

CSS LLC increased its United Therapeutics (UTHR) stake by 6.2% in Q1 2026, buying an estimated $79.7K and bringing the position to 2,757 shares worth $1.63M. The position accounts for 0.08% of the portfolio, ranked #197.

CSS LLC first reported a position in UTHR in Q1 2022 and has held it in 17 quarters since. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • CSS LLC held 2,757 shares of United Therapeutics worth $1.63M as of Q1 2026.
  • CSS LLC bought 160 United Therapeutics shares in Q1 2026, an estimated $79.7K.
  • United Therapeutics made up 0.08% of CSS LLC's portfolio in Q1 2026, its #197 holding.
  • CSS LLC first reported a position in United Therapeutics in Q1 2022 and has held it in 17 quarters since.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on CSS LLC's 13F filing for Q1 2026, filed 15 May 2026.